scholarly journals Repeated transcranial low-level laser therapy for traumatic brain injury in mice: biphasic dose response and long-term treatment outcome

2016 ◽  
Vol 9 (11-12) ◽  
pp. 1263-1272 ◽  
Author(s):  
Weijun Xuan ◽  
Liyi Huang ◽  
Michael R. Hamblin
2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Cheng Ma ◽  
Xin Wu ◽  
Xiaotian Shen ◽  
Yanbo Yang ◽  
Zhouqing Chen ◽  
...  

Abstract Traumatic brain injury (TBI) is exceptionally prevalent in society and often imposes a massive burden on patients’ families and poor prognosis. The evidence reviewed here suggests that gender can influence clinical outcomes of TBI in many aspects, ranges from patients’ mortality and short-term outcome to their long-term outcome, as well as the incidence of cognitive impairment. We mainly focused on the causes and mechanisms underlying the differences between male and female after TBI, from both biological and sociological views. As it turns out that multiple factors contribute to the gender differences after TBI, not merely the perspective of gender and sex hormones. Centered on this, we discussed how female steroid hormones exert neuroprotective effects through the anti-inflammatory and antioxidant mechanism, along with the cognitive impairment and the social integration problems it caused. As to the treatment, both instant and long-term treatment of TBI requires adjustments according to gender. A further study with more focus on this topic is therefore suggested to provide better treatment options for these patients.


2016 ◽  
Vol 135 (1) ◽  
pp. 100-107 ◽  
Author(s):  
B. Johansson ◽  
A.-P. Wentzel ◽  
P. Andréll ◽  
L. Rönnbäck ◽  
C. Mannheimer

2007 ◽  
Vol 24 (4) ◽  
pp. 651-656 ◽  
Author(s):  
Amir Oron ◽  
Uri Oron ◽  
Jackson Streeter ◽  
Luis De Taboada ◽  
Alexander Alexandrovich ◽  
...  

2020 ◽  
Vol 4 (1) ◽  
pp. 29-47
Author(s):  
Sarah Diba ◽  
Maria Mayfinna Gozali ◽  
Yuli Kurniawati

Abstract Female pattern hair loss (FPHL) is the most common hair loss in post-puberty female. Prevalence of this nonscarring alopecia increases with age.  The etiology of FPHL is still unclear, but hormonal and genetic factors are associated with pathogenesis of FPHL. Hormonal factor in FPHL is not as strong as in male pattern hair loss (MPHL). Clinical manifestations of FPHL are characterized by nonscarring baldness with shortening anagen phases and miniaturization of hair follicles, predominantly occur at the vertex, middle, and frontal regions. Hair shedding occurs progressively. The diagnosis of FPHL is established based on clinically. Classification of FPHL is according to Ludwig's criteria. Current FDA-approved FPHL therapy is topical minoxidil 2%, hair transplantation, and low level laser therapy (LLLT). Anti-androgen therapy still needs to be investigated further. The prognosis of FPHL is poor because the progressiveness continues with age. Long term treatment required for FPHL because it is a chronic residif disease. The treatment only prevents the progression of hair loss and does not cure. 


Sign in / Sign up

Export Citation Format

Share Document